...
机译:SARS-COV-2的灭活疫苗候选者的发展
Sinovac Biotech Ltd Beijing Peoples R China;
Chinese Acad Med Sci Beijing Key Lab Anim Models Emerging & Remerging Inst Lab Anim Sci Key Lab Human Dis Comparat Med Chinese Minist Hlt Beijing Peoples R China|Peking Union Med Coll Comparat Med Ctr Beijing Peoples R China;
Zhejiang Prov Ctr Dis Control & Prevent Dept Microbiol Hangzhou Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Natl Inst Food & Drug Control Div Resp Virus Vaccines Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing Peoples R China;
Chinese Acad Med Sci Beijing Key Lab Anim Models Emerging & Remerging Inst Lab Anim Sci Key Lab Human Dis Comparat Med Chinese Minist Hlt Beijing Peoples R China|Peking Union Med Coll Comparat Med Ctr Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Chinese Ctr Dis Control & Prevent Natl Inst Communicable Dis Control & Prevent Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Chinese Acad Med Sci Beijing Key Lab Anim Models Emerging & Remerging Inst Lab Anim Sci Key Lab Human Dis Comparat Med Chinese Minist Hlt Beijing Peoples R China|Peking Union Med Coll Comparat Med Ctr Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Zhejiang Prov Ctr Dis Control & Prevent Dept Microbiol Hangzhou Peoples R China;
Zhejiang Prov Ctr Dis Control & Prevent Dept Microbiol Hangzhou Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Chinese Acad Med Sci Beijing Key Lab Anim Models Emerging & Remerging Inst Lab Anim Sci Key Lab Human Dis Comparat Med Chinese Minist Hlt Beijing Peoples R China|Peking Union Med Coll Comparat Med Ctr Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Chinese Ctr Dis Control & Prevent Natl Inst Communicable Dis Control & Prevent Beijing Peoples R China;
Natl Inst Food & Drug Control Div Resp Virus Vaccines Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing Peoples R China;
Sinovac Biotech Ltd Beijing Peoples R China;
Zhejiang Prov Ctr Dis Control & Prevent Dept Microbiol Hangzhou Peoples R China;
Chinese Acad Med Sci Beijing Key Lab Anim Models Emerging & Remerging Inst Lab Anim Sci Key Lab Human Dis Comparat Med Chinese Minist Hlt Beijing Peoples R China|Peking Union Med Coll Comparat Med Ctr Beijing Peoples R China;
机译:开发灭活疫苗候选者BBIBP-CORV,对SARS-COV-2具有有效的保护
机译:开发和评估福尔马林灭活的西尼罗河病毒疫苗(WN-VAX),用于人类疫苗
机译:在参与者> / = 3岁以下的灭活四价流感疫苗候选与灭活三价流感疫苗的免疫原性和安全性:中国的双盲,随机,平行控股第三阶段临床试验
机译:灭活念珠菌疫苗的Zika病毒的生产和纯化
机译:合理的疫苗开发1)设计三抗原鼻炭疽疫苗候选者2)基于卵磷脂的新型纳米颗粒作为疫苗输送系统。
机译:纯化的SARS-COV-2病毒蛋白的结构蛋白的生物化学和抗原性表征及其在灭活疫苗候选中的纯化SAR-COV-2植物的翻译后修饰
机译:开发灭活疫苗候选者BBIBP-CORV,对SARS-COV-2具有有效的保护
机译:补骨脂素灭活登革病毒1型疫苗候选物在小鼠体内的免疫原性